LBRX Net Income From Continuing Ops from 2010 to 2026
| LBRX Stock | 21.24 1.29 5.73% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -56.8 M | Current Value -54 M | Quarterly Volatility 17.5 M |
Check LB Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LB Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 800, Net Interest Income of 2.1 M or Interest Income of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. LBRX financial statements analysis is a perfect complement when working with LB Pharmaceuticals Valuation or Volatility modules.
LBRX | Net Income From Continuing Ops | Build AI portfolio with LBRX Stock |
Latest LB Pharmaceuticals' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of LB Pharmaceuticals Common over the last few years. It is LB Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LB Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
LBRX Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (21,567,354) | |
| Coefficient Of Variation | (81.36) | |
| Mean Deviation | 12,840,465 | |
| Median | (14,348,000) | |
| Standard Deviation | 17,546,494 | |
| Sample Variance | 307.9T | |
| Range | 56.8M | |
| R-Value | (0.61) | |
| Mean Square Error | 205.8T | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | (2,122,792) | |
| Total Sum of Squares | 4926.1T |
LBRX Net Income From Continuing Ops History
About LB Pharmaceuticals Financial Statements
LB Pharmaceuticals investors use historical fundamental indicators, such as LB Pharmaceuticals' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LB Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -56.8 M | -54 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.